Associate Director, Downstream, Manufacturing Sciences and Technology (Biologics)late jobs in United States
cer-icon
Apply on Employer Site
company-logo

Oruka Therapeutics · 1 month ago

Associate Director, Downstream, Manufacturing Sciences and Technology (Biologics)late

Oruka Therapeutics is developing novel biologics aimed at treating chronic skin diseases. The Associate Director will lead downstream late-stage manufacturing activities, ensuring process development, troubleshooting, and compliance with regulatory standards.

BiotechnologyHealth CareMedical

Responsibilities

Oversee the transfer of manufacturing processes from late-stage development to large-scale production at the CDMOs for multiple programs
Work with CDMOs to identify gaps and implement improvements towards enhancing product quality, robustness, and cost-effectiveness with line of sight to commercial manufacturing
Build strong relationships and partner cross functionally with process development, analytical, formulation, quality, regulatory and program management
Oversee GMP manufacturing campaigns ensuring seamless execution, timely completion and handoff to drug product manufacturing teams
Partner with late-stage process characterization and MSAT teams and develop robust control strategy enabling successful PPQ DS campaigns
Serve as person-in-plant (PIP) during drug substance manufacturing campaigns
Partner with stakeholders to support timely approval and execution of reports, batch records, in-process sampling plans, review SOPs, change controls, deviations, OOS/OOT investigations, and CAPAs
Support regulatory filings by authoring high quality reports enabling timely submissions for multiple jurisdictions (INDs, CTAs)
Perform MFG/MSAT risk assessment activities in a phase appropriate manner ensuring proper measures are in place in support of production and filing requirements
20-25% travel in support of manufacturing activities at CDMOs

Qualification

Downstream process developmentManufacturing ScienceTechnologyPurification process optimizationRegulatory compliance knowledgeMonoclonal antibodies experienceDesign-of-experiments (DoE)Data analysis skillsPeople management skillsCommunication skillsStrategic mindset

Required

Master's or a PhD degree in biochemistry, biochemical engineering, biotechnology or equivalent with at least 8 years of relevant experience developing, scaleup, and transfer of downstream processes for biologics
Significant experience managing manufacturing in an MSAT environment. Direct hands-on experience with monoclonal antibodies is a plus
Expertise in purification process optimization with an emphasis on scale-up, scale-down models, process robustness, facility fit and overall commercial readiness
In depth knowledge of CMC, quality and compliance, as well as regulatory aspects of biopharmaceutical development and life-cycle management
Must have a solid understanding of all downstream unit operations, process parameters, product quality, and troubleshooting strategies enabling successful execution of phase appropriate manufacturing campaigns
Demonstrated track record of successful tech transfers to CDMOs with an eye towards late stage and commercial process development
Must have direct experience or exposure to transition of processes from early stage to late stages such as process characterization, FMEA and PPQ campaigns, with emphasis on phase appropriate control strategy
Direct experience in design-of-experiments (DoE) and robust data analysis via industry standard statistical tools
Excellent writing, organization, communication and people management skills with the ability to work effectively with a diverse group of internal and external stakeholders
Self-starter with a strategic mindset and ability to thrive in a fast-paced, collaborative environment

Benefits

A chance to be part of a vibrant startup culture where your work can directly impact bringing new medicines to patients.
Competitive salary and benefits package.
A supportive and inclusive team environment where everyone is encouraged to bring their authentic selves to work.
Opportunities for professional growth and development.

Company

Oruka Therapeutics

twittertwitter
company-logo
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Funding

Current Stage
Public Company
Total Funding
$455M
Key Investors
Viking Global Investors
2025-09-17Post Ipo Equity· $180M
2024-09-03Post Ipo Equity· $275M
2024-09-03IPO
Company data provided by crunchbase